Clinical chemistry analytical platform with reagents
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- W81K0213D0002
- Awardee
-
Abbott Laboratories Inc. UEI NH3LDK8CFAK7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Task orders
- 5 $5,362,216 obligated
Award facts
- Opportunity
-
- W81K0212R0081 Solicitation number
- Clinical chemistry analytical platform system with reagents Award Notice · Posted Oct 3, 2012
- Combined order value
- $5,362,216 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 64% used
- $8,401,816.38
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract (IDC) was awarded by the U.S. Army Medical Command (MEDCOM) to Abbott Laboratories Inc., a global healthcare company and manufacturer of medical devices, diagnostic products, and pharmaceutical goods. The $8.4 million single-award IDC provides MEDCOM with a clinical chemistry analytical platform, including reagents, automated analyzers, and associated medical testing equipment and services.
The contract has been fulfilled through a series of firm fixed-price delivery orders over a multi-year period from 2013 to 2017. The delivery orders, valued between $0.8 million and $1.2 million each, have supplied MEDCOM with a variety of clinical laboratory testing capabilities, including chemistry, immunochemistry, and immunoassay testing services, as well as reagents and test kits. The contract leverages Abbott's existing General Services Administration (GSA) Federal Supply Schedule contract to streamline procurement of these critical medical diagnostic products and services for federal healthcare operations.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Aero-C8K ICT module - 09D2803 SAF FY17 do | Medical Command (Army) | $1,141,480 | |
| Delivery order 0004 reagents | Medical Command (Army) | $1,177,299 | |
| Delivery order 0003 | Medical Command (Army) | $1,103,122 | |
| Delivery order 0002 under option year 1 for reagents. | Medical Command (Army) | $1,158,201 | |
| Base year delivery order | Medical Command (Army) | $782,114 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Show all 13
Quick answers
Who was awarded contract W81K0213D0002?
W81K0213D0002 was awarded to Abbott Laboratories Inc. by Medical Command (Department of the Army) on February 11, 2013.
How much is contract W81K0213D0002 worth?
Orders under W81K0213D0002 have obligated $5,362,216. W81K0213D0002's own ceiling is $8,401,816.
How many orders have been placed under contract W81K0213D0002?
5 orders have been placed under W81K0213D0002, the latest on October 1, 2016.
Who can order from contract W81K0213D0002?
W81K0213D0002 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract W81K0213D0002 competed?
The extent of competition for W81K0213D0002 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV